Cargando…

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment

The microtubule-stabilizing agent docetaxel in combination with gemcitabine represents one of the most effective regimens against the aggressive gynecologic tumor leiomyosarcoma (LMS). Upregulation of class III β-tubulin has previously been shown to confer taxane resistance in a variety of human can...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reader, Jocelyn, Harper, Amy K., Legesse, Teklu, Staats, Paul N., Goloubeva, Olga, Rao, Gautam G., Fulton, Amy, Roque, Dana M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826612/ https://www.ncbi.nlm.nih.gov/pubmed/31635323 http://dx.doi.org/10.3390/cancers11101590

Ejemplares similares

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties
por: Kundu, Namita, et al.
Publicado: (2013)

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE(2)-mediated immunosuppression and inhibits breast cancer metastasis
por: Ma, Xinrong, et al.
Publicado: (2013)

The Role of Eicosanoids in Gynecological Malignancies
por: Smith, Paige G., et al.
Publicado: (2020)

Eicosanoids in Cancer: Prostaglandin E(2) Receptor 4 in Cancer Therapeutics and Immunotherapy
por: Ching, Mc Millan, et al.
Publicado: (2020)

Class III β-tubulin expression and in vitro resistance to microtubule targeting agents
por: Stengel, C, et al.
Publicado: (2010)

Class III β-Tubulin Counteracts the Ability of Paclitaxel to Inhibit Cell Migration
por: Ganguly, Anutosh, et al.
Publicado: (2011)

High expression of class III β-tubulin in small cell lung carcinoma
por: POWELL, STEVEN, et al.
Publicado: (2014)

High expression of class III β-tubulin in upper gastrointestinal cancer types
por: Höflmayer, Doris, et al.
Publicado: (2018)

Upregulation of Cyclooxygenase-2/Prostaglandin E(2) (COX-2/PGE(2)) Pathway Member Multiple Drug Resistance-Associated Protein 4 (MRP4) and Downregulation of Prostaglandin Transporter (PGT) and 15-Prostaglandin Dehydrogenase (15-PGDH) in Triple-Negative Breast Cancer
por: Kochel, Tyler J., et al.
Publicado: (2016)

Rationalization of paclitaxel insensitivity of yeast β-tubulin and human βIII-tubulin isotype using principal component analysis
por: Das, Lalita, et al.
Publicado: (2012)

Antisense oligonucleotides to class III β-tubulin sensitize drug-resistant cells to Taxol
por: Kavallaris, M, et al.
Publicado: (1999)

Increased expression of class III β-tubulin in castration-resistant human prostate cancer
por: Terry, S, et al.
Publicado: (2009)

Expression of the Class II and III Beta-Tubulin in Neoplastic and Non-Neoplastic Lymphoid Tissues
por: Yusof, Nor Syahida Binti, et al.
Publicado: (2017)

The Amazing Evolutionary Complexity of Eukaryotic Tubulins: Lessons from Naegleria and the Multi-tubulin Hypothesis
por: Fulton, Chandler
Publicado: (2022)

Combined inhibition of IL-6 and IL-8 pathways suppresses ovarian cancer cell viability and migration and tumor growth
por: Zhang, Ruijie, et al.
Publicado: (2022)

Hair follicle bulge cultures yield class III β-tubulin-positive melanoglial cells
por: Locher, H., et al.
Publicado: (2015)

Class III β-Tubulin in Colorectal Cancer: Tissue Distribution and Clinical Analysis of Chinese Patients
por: Zhao, Xiaoli, et al.
Publicado: (2016)

Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer
por: Martinelli, Enrica, et al.
Publicado: (2018)

Class III β-Tubulin Overexpression Induces Chemoresistance to Eribulin in a Leiomyosarcoma Cell Line
por: Yahiro, Kenichiro, et al.
Publicado: (2018)

Expression of Class III Beta-Tubulin Is Associated with Invasive Potential and Poor Prognosis in Thyroid Carcinoma
por: Na, Hee Young, et al.
Publicado: (2020)

Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer
por: Kochel, Tyler J, et al.
Publicado: (2016)

Barriers to Timely Completion of Radiation Therapy in Patients with Cervical Cancer in an Urban Tertiary Care Center
por: Cohen, Justin, et al.
Publicado: (2017)

High levels of class III β-tubulin expression are associated with aggressive tumor features in breast cancer
por: LEBOK, PATRICK, et al.
Publicado: (2016)

Axonal transport of class II and III beta-tubulin: evidence that the slow component wave represents the movement of only a small fraction of the tubulin in mature motor axons
Publicado: (1992)

Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
por: Hwang, Jun-Eul, et al.
Publicado: (2013)

Class III β-tubulin expression as a predictor of docetaxel-resistance in metastatic castration-resistant prostate cancer
por: Maahs, Lucas, et al.
Publicado: (2019)

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells
por: Kundu, Namita, et al.
Publicado: (2019)

Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer
por: Du, Jintong, et al.
Publicado: (2015)

Microtubule-Associated Protein Tau, α-Tubulin and βIII-Tubulin Expression in Breast Cancer
por: Im, Soyoung, et al.
Publicado: (2013)

Overexpression of Class III Beta Tubulin and Amplified HER2 Gene Predict Good Response to Paclitaxel and Trastuzumab Therapy
por: Jung, Minkyu, et al.
Publicado: (2012)

βIII-Tubulin Gene Regulation in Health and Disease
por: Duly, Alastair M. P., et al.
Publicado: (2022)

Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
por: Wang, Amy
Publicado: (2012)

Prognostic value of vascular endothelial growth factor receptor 1 and class III β-tubulin in survival for non-metastatic rectal cancer
por: Kong, Xiang-Quan, et al.
Publicado: (2018)

Voltage-Clamp Studies on Uterine Smooth Muscle
por: Anderson, Nels C.
Publicado: (1969)

Calcium diffusion in uterine smooth muscle sheets
Publicado: (1982)

Microtentacle Formation in Ovarian Carcinoma
por: Reader, Jocelyn C., et al.
Publicado: (2022)

β class II tubulin predominates in normal and tumor breast tissues
por: Dozier, James H, et al.
Publicado: (2003)

Steady-state approximations for Hodgkin-Huxley cell models: Reduction of order for uterine smooth muscle cell model
por: Means, Shawn A., et al.
Publicado: (2023)

Slug increases sensitivity to tubulin-binding agents via the downregulation of βIII and βIVa-tubulin in lung cancer cells
por: Tamura, Daisuke, et al.
Publicado: (2013)

Evolutionary dynamics of cancer multidrug resistance in response to olaparib and photodynamic therapy
por: Baglo, Yan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gl0ev9kngm01vgvjvk6qtnd4tp